| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.008 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.008 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | 0.092 | 0.009 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.22 | 0.009 |
| mRNA | pitstop2 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.009 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | 0.086 | 0.01 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | 0.2 | 0.01 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.092 | 0.01 |